Urologist Peter L. Scardino, MD, co-founder of Memorial Hospital in Savannah, GA, passed away July 21 at his home in Savannah.
Collaboration to advance market launch of ProVate device for pelvic organ prolapse
The company expects the device to become available for US patients with pelvic organ prolapse in September 2024.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Darolutamide associated with more favorable tolerability vs other ARIs in nmCRPC
“Our study reveals potential differences in tolerance and effectiveness of AR inhibitors in practice, which can help clinicians and patients with treatment decisions," says Daniel J. George, MD.
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.
Study reveals disparities in immunotherapy use for patients with kidney, bladder cancer
“Our study highlights critical gaps in health care equity when it comes to treatments that have been shown effective in prolonging survival,” says Solomon Woldu, MD.
FDA grants rare pediatric disease designation to YOLT-203 for primary hyperoxaluria type 1
YOLT-203 is currently being assessed in the early phase 1 YOLT-203-101 trial.